Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02485288 · ClinicalTrials.gov registry record
PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort
A clinical trial of Atrial Fibrillation, sponsored by University of Pittsburgh.
- Active
- Registry status
- 1,500
- Enrollment target
- 4
- Study locations
NCT02485288 is a study of Atrial Fibrillation that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 1,500 participants, below the 2,989-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (50% lower). The trial reports 4 study locations across 2 states.
The verdict
NCT02485288, a study of Atrial Fibrillation, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 1,500 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the PaTH Network AF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients, providers, and other stakeholders.
Conditions Studied
Study Locations (4)
Pennsylvania
- Jody McCullough - Hershey
- Anuradha Paranjape - Philadelphia
- University of Pittsburgh - Pittsburgh
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2015-06 |
| Est. Completion | 2030-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02485288
The ClinicalTrials.gov registry entry for NCT02485288 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,989-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (50% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Atrial Fibrillation appearing as the primary indexed condition, and to 0 interventions.
NCT02485288 reports 4 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, Maryland.
Frequently Asked Questions
What is clinical trial NCT02485288 about?
NCT02485288 is a clinical study titled "PaTH Clinical Data Research Network (CDRN) Atrial Fibrillation (AF) Clinician-Patient Partnership Cohort". The purpose of the PaTH Network AF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients, providers, and other stakeholders.
What is the current status of trial NCT02485288?
This trial is currently active not recruiting. The enrollment target is 1,500 participants. The study started on 2015-06. Estimated completion is 2030-07.
What conditions does trial NCT02485288 study?
This clinical trial studies the following conditions: Atrial Fibrillation.
Who is sponsoring clinical trial NCT02485288?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02485288 being conducted?
This trial has 4 study locations across Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.